Return to site

SAVA HEALTHCARE RECEIVES RUSSIAN GMP APPROVAL FOR ITS DPI CAPSULE 

SAVA Healthcare receives Minzdrav Rossii (Russia) GMP approval for its dry powder inhalation (DPI) capsule manufacturing unit based in Surendranagar, Gujarat, India.

SAVA HEALTHCARE LIMITED INDIA which specializes in the manufacturing and marketing of Nasal Sprays and Dry Powder Inhalers (DPI) announced the Russian Ministry of Health (MOH), Minzdrav Rossii, has approved its DRY POWDER INHALER (DPI) capsules manufacturing line for the Respiratory Therapeutic segment. This decision will strengthen SAVA’s presence in the RUSSIAN AND CIS regions.

SAVA has developed the latest generation of DPIs including Tiotropium, Formeterol, salmeterol/fluticasone, Budesonide/Formeterol Fumarate for Russian and other CIS markets.

SAVA’s Surendranagar facility is accredited by HEALTH CANADA, PICs Ukraine, WHO-GMP, amongst other Drug Administration authorities.

DSIR approved in-house R&D Center of SAVA at Pune, India is a well-equipped Formulations R&D center catering to Dry Powder Inhaler (DPI) development and has best-in-class R&D equipment like Dosage Unit Sampling Apparatus (DUSA), NextGen Impactor (NGI), and Glass Twin Impinger (T1, T2).

Mr. Vinod Ramchandra Jadhav, Chairman of SAVA Group, commented, “This endorsement of SAVA’s commitment to meeting GMP guidelines is welcoming news and gives SAVA access to the RUSSIAN pharmaceutical market which is estimated at 22 billion USD and growing by 10%. The respiratory drug category is the second fastest growing segment.”

Organisation: SAVA HEALTHCARE LTD

Name: Mr.Naresh B Katara, Chief Executive Officer (CEO)

Email: sales@savaglobal.com;

Registered office :SAVA House, Viman Nagar, Pune 411014, Maharastra, India

Phone: +912030516100,FAX: +912030516161

WEB: www.savaglobal.com

About SAVA
SAVA HEALTHCARE LTD is amongst one of the fastest emerging pharmaceutical organizations of repute from India and has attained an iconic stature in pharmaceutical arena making the lives of millions of people feel good.

Our well-known Pharmaceutical manufacturing plant located, in Surendranagar near Ahmedabad in India, helps SAVA attain its magnanimous capability of "curative power" by producing over 500 products in what stands as one of the widest range of therapeutic categories in India.
The SAVA group of companies constitutes independent and well-established entities in manufacturing, marketing, retail and distribution to cover the entire value-chain in pharmaceuticals. 
Along with strategically prominent marketing nodes the world over, SAVA gives the edge to be self-sustained in effectively delivering our vast range of products across various geographies. It also serves to fulfil our commitment to deliver "beyond the maxim of care".

SAVA HEALTHCARE LIMITED internationally is present in 50+ countries with more than 300 + product registrations. SAVA specialises in Dry Powder inhalers (DPI) , Nasal Sprays, Tablets and Capsules, Dermatology, Veterinary Products, and USDA approved Herbal Extracts.

Organisation: SAVA HEALTHCARE LTD

Name: Mr.Naresh Katara /CEO /Email: ceo@savaglobal.com; Registered office :Sava House , Sakorenagar CHS ,Off New Airport road , Viman Nagar , Pune 411014 , Maharastra , India

Phone : +912030516100,FAX: +912030516161 WEB : www.savaglobal.com

All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly